The BRAF(V600E) mutation has been found in 8%–10% of metastatic colon cancer patients [11]; approximately half of papillary thyroid carcinomas and melanomas exhibit the BRAF(V600E) mutation [12]. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.